The APAC region has emerged as a leader in the global clinical trial landscape, attributable to several key factors including a large, diverse patient population with a large proportion of treatment-naïve people, cost effectiveness in conducting clinical trials and a favorable regulatory environment.
China Dominates APAC’s Emergence As Global Trials Hub
39% Of Total Trial Starts In ’23
Asia-Pacific continues to solidify its position as a key location for clinical trials, with China in particular dominating such activity in the region, and increasingly globally, a new Citeline White Paper shows.
